title: [Cytolytic hepatic lesion associated with the ingestion of piretanide].
authors.forename: G
authors.initials: G
authors.lastname: Bellaïche
authors.forename: N
authors.initials: N
authors.lastname: Lamouri
authors.forename: J L
authors.initials: JL
authors.lastname: Slama
authors.forename: G
authors.initials: G
authors.lastname: Ley
authors.forename: B
authors.initials: B
authors.lastname: Paugam
mesh_terms: D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D004232:Diuretics / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008111:Liver Function Tests; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D004232:Diuretics; D013449:Sulfonamides; C015451:piretanide
vernacular_title: Atteinte hépatique cytolytique associée à la prise de pirétanide.